CohnReznick Logo
Cannabis horizons: Charting the path forward
Now available on-demand

The Details
The DEA’s potential rescheduling of cannabis from Schedule I to Schedule III serves as a linchpin in the industry’s optimistic trajectory. Rescheduling would have a domino effect on the industry and how it operates.

Don't miss this opportunity to gain a deeper understanding of where the cannabis industry is headed – and how you can navigate the evolving landscape. Our panel of cannabis industry professionals will share their unique insights and predictions for what they believe lies ahead over the next six months, two years, and five years. The discussion will focus on the current landscape related to DEA rescheduling and the impact it will have on M&A activity and related business valuations.

Recorded on April 23, 2024.


Tara Marino Photo
Tara Marino
Principal, Valuation Advisory

Lane Burns Photo
Lane Bruns

Tracy Gallegos Photo
Tracy Gallegos
Duane Morris

Robert G. Shuler
Managing Partner
Dye Capital

3-Col Headline